Rational targeting Cdc42 restrains Th2 cell differentiation and prevents allergic airway inflammation
Clinical & Experimental Allergy2018Vol. 49(1), pp. 92–107
Citations Over TimeTop 17% of 2018 papers
Jun‐Qi Yang, Khalid W. Kalim, Yuan Li, Xin Duan, Phuong Nguyen, Gurjit K. Khurana Hershey, John Kroner, Brandy Ruff, Li Zhang, Nathan Salomonis, Mark Rochman, Ting Wen, Yi Zheng, Fukun Guo
Abstract
Cdc42 is required for Th2 cell differentiation and allergic airway inflammation, and rational targeting Cdc42 may serve as a preventive but not therapeutic approach for asthma control.
Related Papers
- → Platelet-Derived Extracellular Vesicles as Lipid Carriers in Severe Allergic Inflammation(2023)8 cited
- → β-Glucan plus LPS promote neutrophilic inflammation in OVA-induced allergic inflammation.(2015)
- Inhibitory Effect of CM and PM on IgE-Mediated Allergic Responses and Ovalbumin-Induced Lung Inflammation In vitro and In vivo(2013)
- → CHOICE OF AN OPTIMAL MODEL OF OVALBUMIN-INDUCED ALLERGIC AIRWAYS INFLAMMATION TO ASSESS THE INFLAMMATORY RESPONSE IN MICE EXPOSED TO TAIL SUSPENDED SIMULATION OF THE EFFECTS OF MICROGRAVITY(2019)
- → MORPHOLOGICAL CHANGES IN ALVEOLAR MACROPHAGES OF GUINEA PIGS IN THE EARLY AND LATE STAGES OF EXPERIMENTAL OVALBUMIN-INDUCED ALLERGIC INFLAMMATION(2022)